Dear Mr. Abhishek and Mr. Suresh,
I would like to kindly address you from
the Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi,
Georgia.
Please be informed that the provided
draft letter of Agreement does not cover the required provisions necessary to
formalize contractual relations between our parties. Therefore, we would like
to share with you our draft procurement agreement for your revision. Please
kindly send your comments/suggestions at your earliest convenience.
As for the import license, please note
that according to the sub-paragraph „a“ of the Article 1113 of Georgian Law on
“Medicines and Pharmaceutical Activities”, pharmaceutical product may be
imported circumventing the regimes for granting marketing authorization in
Georgia for non-commercial purposes in case of
pre-clinical and clinical trials. The medicine “Remdesivir” will
be used within the World Health Organization’s international randomized
clinical trial “SOLIDARITY” and consequently, import license is not
required.
Hereby, please be informed that in the
attached draft Agreement is mentioned that the procured medication will be used
only for non-commercial purposes by the medical facilities involved in the
trial. However, if you still require the confirmation letter, the AIDS Center
will proceed.
We look forward to receiving your
feedback soon.
Thank you for continued cooperation and
support.
Best regards,
Shota Gogichaishvili MD, PhD
Executive director
Infectious Diseases, AIDS and Clinical
Immunology Research Center, Tbilisi, Georgia.